MedTrace Logo

Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)

NCT06222788 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-06-27

No results posted yet for this study

Summary

The goal of this clinical trial is to test the safety of the use of non-thermal plasma (NTP, an ionized gas) on the tumor bed after the removal of the tumor in breast cancer patients. The main questions it aims to answer are:

* To determine the safe and tolerable dose of NTP in patients with breast cancer;
* To assess the safety and tolerability of NTP;
* To assess the cosmetic effects of NTP treatment in patients with breast cancer. Participants will receive one treatment of the tumor bed after the removal of their breast tumor.

Conditions

Interventions

DEVICE

Convertible Plasma Jet

NTP will be applied to the patients using the Convertible Plasma Jet (CPJ, NexPlasmaGen Inc.)

Sponsors & Collaborators

  • Ozmosis Research Inc.

    collaborator INDUSTRY

  • Ministère de l'Économie, de l'Innovation et de l'Énergie, Québec, Canada

    collaborator UNKNOWN

  • Quebec Breast Cancer Foundation

    collaborator OTHER

  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06222788 on ClinicalTrials.gov